(c) http://www.californiaivf.com/ |
The
government is planning to draft new regulations allowing three-person IVF that
could see the procedure being made available to couples in the United Kingdom
within two years. According to experts, the technique could eliminate the
debilitating and sometimes fatal mitochondrial diseases that are passed from
the mother to the child and could help up to 10 couples a year.
Mitochondria
convert energy so that it can be used by cells and are passed, via the egg,
from the mother to the baby. Defective mitochondria can leave cells starved of
energy resulting in blindness, weak muscles, heart failure and even death in
extreme cases. About one in 6,500 babies are affected by defective mitochondria.
Research
indicates that mitochondria from a donor egg can prevent mitochondrial
diseases. However, the technique would mean that babies end up with DNA from
three people - both parents and a third donor - as mitochondria have their own
DNA, and would inherit genetic information from three. They would have over
20,000 genes from their parents and 37 from the donor.
Newcastle
University is pioneering one of the three-person IVF techniques. Professor DougTurnbull, a researcher at Newcastle, believes that the introducing the
procedure is great news for those families affected by mitochondrial disease.
It will give them more reproductive choice and the chance to have children who
are free from the disease.
Following
public consultation earlier this year, the Human Fertilisation and Embryology
Authority found that there was ‘general support’ for the new technique and
there was no evidence to suggest that it was not safe. According to ProfessorSally Davies, Chief Medical Officer for England, "Scientists
have developed ground-breaking new procedures which could stop these disease
being passed on, bringing hope to many families seeking to prevent their future
children inheriting them. It's only right that we look to introduce this
life-saving treatment as soon as we can." She acknowledges that there are
sensitive issues involved but is personally comfortable with the proposal.
There
have been objections to the proposed procedure from the outset, as it will have
ramifications for generic inheritance. Dr. David King, Director of HumanGenetics Alert, says that it is unsafe and unnecessary and the majority of
respondents in the consultation, in fact, rejected the proposal. He claims that
the consultation was inadequate and biased and that it would be a disaster to
base a decision that could eventually lead to a ‘eugenic designer baby market’
based on its findings.
Despite
these concerns, draft regulations on the use of the treatment are to be
produced this year, ready for a final version to be debated and voted upon in
Parliament next year. As yet, the details have to be decided. It is likely that
the procedure will be available only to those with the most severe cases and that
those children born as a result of the procedure will not have the right to
know the identity of the donor and will be subject to lifelong monitoring.
Introducing
these regulations now, says Academy of Medical Sciences President Sir JohnTooke, means that there will be no unnecessary delay in offering the treatment
to affected families once there is adequate proof that it is safe and
effective. It will also keep the United Kingdom to the fore of cutting-edge
research in the field.
No comments:
Post a Comment